orforglipron

Lilly links oral obesity drug to 15% weight loss, setting bar for Pfizer in blockbuster battle
Fierce Biotech
Mon, 06/26/23 - 10:00 am
Eli Lilly
obesity
orforglipron
Pfizer
Novo Nordisk
Mounjaro
ADA 2023 preview – Lilly’s oral obesity data leave room for Pfizer
EP Vantage
Wed, 06/21/23 - 10:38 am
ADA
Eli Lilly
Pfizer
diabetes
obesity
orforglipron
danuglipron
lotiglipron
Lilly steps up its oral obesity push
EP Vantage
Thu, 05/25/23 - 08:45 pm
Eli Lilly
obesity
GLP-1 agonist
orforglipron
Lilly and Pfizer fight for new territory in obesity and diabetes
EP Vantage
Thu, 12/15/22 - 10:46 am
Eli Lilly
Pfizer
obesity
diabetes
orforglipron
Mounjaro